D. Scott Hemingway

I'll research this attorney before drafting.

Let me dig into his PTAB/IPR record and notable patent cases.

D. Scott Hemingway — patent litigation summary

Specialty / focus. Hemingway is a registered patent attorney whose practice sits at the intersection of IP litigation, prosecution, and licensing, with a technical foundation in electrical engineering and computer science (B.S. in EE/CS/computer engineering, SMU, 1988). His patent work skews toward electronics and telecom rather than pharma: firm materials describe prosecuting and managing "several hundred" cellular telecommunication protocol applications for Nortel Networks, and public dockets place him in semiconductor-packaging and electronics matters (PTAB IPR2018-00828 concerning U.S. Pat. 7,124,927, a solder-ball-bumping patent) and medical-device cases (Reaux Medical Industries v. Stryker Corp., N.D. Tex. 2012, asserting U.S. Pat. 8,261,375 on sterile hoods). He also handles trade secret and copyright matters, including Wellogix v. Accenture and Granville v. Sony BMG.

Side preference. The authoritative tracked data show a single appearance, on the plaintiff side as Counsel — consistent with the public record, which is predominantly patent-owner/inventor-side: Reaux Medical (as plaintiff), Tidel Engineering v. Corporate Safe Specialists (N.D. Tex. 2005, lead attorney for Tidel), and the Red River Fiber Optic matter. There is no tracked defendant-side appearance. The firm publicly describes itself as handling both enforcement and defense of infringement accusations, so the plaintiff lean reflects the observed record rather than an express limitation.

Firm context. He is a named partner at Hemingway & Hansen LLP, a Dallas IP boutique he co-founded with Eugenia S. Hansen (firm materials date the founding to October 2005, though one directory lists him as partner there from 1999). Before that he was at Jones Day (1997–1999) and Richards, Medlock & Andrews (1991–1997). He is not in-house; he practices in a small boutique where clients are handled directly by the named partners.

Notable matters, PTAB, and bar. Firm-reported results include the Wellogix trade-secret jury award against Accenture (reported at over $94 million in compensatory and punitive damages, later paid/settled), roughly $20 million in licensing and settlement recoveries in the Red River Fiber Optic communications matter, and a willful-copyright-infringement jury verdict with maximum statutory damages in Granville v. Sony BMG, with a related Fifth Circuit reversal of summary judgment. These figures come from the attorney's own published case descriptions and should be treated as self-reported pending independent verification. On the PTAB side, he appears as counsel of record in IPR2018-00828 (Avant Technology v. Anza Technology), where the Board denied institution; the available public filings do not make clear which party he represented, so that should be confirmed before relying on it. He is admitted in Texas (1991) and Georgia, is a registered patent attorney (USPTO Reg. No. 36,366), and is admitted to the Federal Circuit (1993), the Fifth Circuit (2005), and the U.S. Supreme Court (1998); J.D., Emory University School of Law (1991).

Caveat: the tracked case list supplied to me contains one unidentified plaintiff-side matter, so the "1 appearance" figure likely understates his actual litigation history; firm and directory descriptions were used to fill out the practice picture.